36C24423Q0964_4.docx

36C24423Q0964

GENERAL INFORMATION

Network Contracting Office 4 WVAMC Wilmington VA Medical Center 1601 Kirkwood Highway Wilmington, DE 19805

POINT OF CONTACT*

Contracting Officer Debra Willard debar.willard@va.gov

PLACE OF PERFORMANCE

Network Contracting Office

WBVAMC Wilkes Barre VA Medical Center

1111 East End Blvd

Wilkes Barre PA

COUNTRY

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

QUSTIONS AND ANSWERS BELOW:

ATTACHED UPDATED RFQ:

QUESTIONS:

If we compare personnel sampling:

Section 6 - Initial gloved fingertip and thumb sampling-8 staff for initial testing per year (64 samples) + 35 staff bi-annual fingertip and thumb samples (280 samples) gives a total of 344 samples.

Section 10 - line item 0001 shows 118 samples.

There is a difference between them since one indicates 344 samples and the other 118.

If we compare surface sampling:

Section 6 - 35 staff bi-annual surface samplings conducted post media-fill (70 samples) + 13 total surface samplings monthly for IV compounding areas, sample locations to be determined by WBVAMC (130 samples) gives a total of 143 samples.

Section 10 - line item 0002 shows 226 samples There is a difference between them since one indicates 143 samples and the other 226.

ANSWERS:

10. Number of samples:

0. Initial gloved fingertip and thumb sampling-8 staff for initial testing per year (64 samples)

0. 35 staff bi-annual fingertip and thumb samples (280 samples)

0. 35 media-fill tests bi-annually (70 samples)

0. 35 staff bi-annual surface samplings conducted post media-fill (70 samples)

0. 13 total surface samplings monthly for IV compounding areas, sample locations to be determined by WBVAMC (130 samples)

0. Analysis of EM (TBC, TFC, TMC only)- per plate submitted. Covers surface samples and GFT samples from line a,b,d and e.

0. Media Fill -samples incubated per USP and FDA aseptic guidelines.be visually evaluated after 7 days of incubation at 20 to 25C and after 7 additional days of incubation at 30 to 35C for turbidity from line C.

*These numbers are correct. I updated f and g because it wasn’t referencing the correct lines.*

Item # 0001- 344 (GFT) – if this is the actual plates and NOT the analysis then 360 would be best 0002- 200 (surface sampling) – if this is the actual plates and NOT the analysis- 210 would be best 0003-70 (media fill) -- supply 0004- analysis of EM- 344 +200= 544 total 0005- analysis of media fill- 70 total

*The analysis of the testing is charged per plate*

Amendment to a Previous Combined Solicitation

Amendment to a Previous Combined Solicitation

Page 1 of

Amendment to a Previous Combined Solicitation

PAGE 1 OF

1. REQUISITION NO.

2. CONTRACT NO.

3. AWARD/EFFECTIVE DATE

4. ORDER NO.

5. SOLICITATION NUMBER

6. SOLICITATION ISSUE DATE

a. NAME

b. TELEPHONE NO. (No Collect Calls)

8. OFFER DUE

DATE/LOCAL

TIME

9. ISSUED BY

CODE

10. THIS ACQUISITION IS

UNRESTRICTED OR

SET ASIDE:

% FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ

IFB

RFP

15. DELIVER TO

CODE

16. ADMINISTERED BY

CODE

17a. CONTRACTOR/OFFEROR

CODE

FACILITY CODE

18a.

PAYMENT WILL BE MADE BY

CODE

TELEPHONE NO.

UEI:

EFT:

PHONE:

FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER 18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE

ADDENDUM

19.

20.

21.

22.

23.

24.

ITEM NO.

SCHEDULE OF SUPPLIES/SERVICES

QUANTITY

UNIT

UNIT PRICE

AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA

26.

TOTAL AWARD AMOUNT (For Govt. Use Only) 27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA

ARE

ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212

-4. FAR 52.212-5 IS ATTACHED. ADDENDA

ARE

ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________

29. AWARD OF CONTRACT: REF. ___________________________________ OFFER

COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND

DATED ________________________________. YOUR OFFER ON SOLICITATION

DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY

(BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE

ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED

SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNAT

URE OF OFFEROR/CONTRACTOR

31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER) 30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION

(REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE

Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

693-23-3-093-0902 36C24423Q0964 06-29-2023 Debra Willard | debra.willard@va.gov 06-26-2023 12:00 pm

EDT

00244 Department of Veterans Affairs Network Contracting Office 4 PVAMC Pittsburgh VA Medical Center University Drive Campus Pittsburgh PA 15215 X X 621511 $36.5 Million N/A X

00244 Department of Veterans Affairs Network Contracting Office 4 WVAMC WIlmington VA Medical Center 1601 Kirkwood Highway Wilmington DE 19805

Austin Payment Center Department of Veterans Affairs PO Box 149971 Austin TX 78714-9971

(877) 353-9791

(512) 460-5429 See CONTINUATION Page GFT Medi Testing Pittsburgh VA Medical Center Submit quotes by 06/26/2023 at 12:00 PM EST.

Email quotes to debra.willard@va.gov See CONTINUATION Page X X Debra Willard Contracting Officer Page 1 of Page 1 of Table of Contents

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

a. CONTRACTOR:

b. GOVERNMENT: Contracting Officer 36C244 Debra Willard Department of Veterans Affairs Network Contracting Office 4 PVAMC Pittsburgh VA Medical Center University Drive Campus Pittsburgh PA 15215

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

3. INVOICES: Invoices shall be submitted in arrears:

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.

ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:

Page 1 of Page 1 of Page 1 of Page 1 of Statement of Work for Environmental Microbiology Laboratory Analytical Services

1. General Requirements:

Brand name or Equal ISO/TEC 17025 accredited laboratory under the Environmental Microbiology Lab Accreditation Program (EMLAP) will process (incubate, analyze, record and report results) microbiological surface samples, Gloved Fingertip and Thumb samples (GFT) and Media Fill Testing (MFT) samples obtained and submitted by Wilkes-Barre Veterans Medical Center (WBVAMC). Samples will be processed according to the most current version of CAG-009-2011 (or its successor) and results will be compared to recommendations provided in USP <797>.

MUST BE FDA REGISTERED.

Base plus 4 option years.

All sampling supplies, plates and media fill will be provided by the laboratory pursuant to this contract. Certificate of analysis from the manufacturer will be provided for each lot of growth media to verify that the media meet the expected growth promotion, pH, and sterilization requirements.

The contractor shall process personnel related assessment testing GFT samples according to CAG-009-2011 (or its successor), and 2022 USP <797> standards (or newest version). GFT results will be reported for each plate, with the amount of colony forming units (cfu) present on each plate reported. If there is no growth present that shall be indicated on the report (0 CFU or < 1 CFU).

The contractor shall process MFT samples according to CAG-009-2011 (or its successor) and 2022 USP <797> standards (or newest version). MFT results will be reported as negative (pass) or positive (fail); failure is indicated by visible turbidity or other visual manifestations of growth in the media in one or more container–closure unit(s) on or before 14 days.

The contractor shall process viable surface samples according to the most current version of CAG-009-2011 and USP <797> standards. If cfu measured during viable sampling exceed USP <797> threshold levels, the report will at minimum identify genus and, when possible, species of any microorganism recovered on the report, in addition to the sample name and the number of CFU. If there is no growth present that shall be indicated on the report (0 CFU or < 1 CFU).

2. Scope:

The contractor shall perform routine work detailed in this Statement of Work (SOW) on a regular schedule, mutually agreed upon by the Contractor and Contracting Officer Representave (COR). The majority of the staff will be tested for GFT and Media fill on a twice yearly basis. Any newly hired staff will need to be tested on an adhoc basis according to the start date in the service.

The number of surface sampling, gloved fingertip testing (GFT) and media fill testing (MFT) may change throughout the contract period. This is WBVAMC’s best estimate of the number and type expected to be tested and sampled by the contract. WBVAMC reserves the right to delete or add units as required.

If the numbers of listed items will be exceeded, no work is authorized without the prior written approval of the Contracting Officer (CO) to account for it. Work items or services not already included in this SOW, but relevant to it, may be ordered by the CO without further competition. Only the CO has the right to obligate funding or order work not expressly detailed in this SOW. The Government shall not be held responsible for payment for any work performed by the Contractor that is outside the scope of this contract or without the prior approval of the CO.

3. Task:

a. Bacteria and Fungi surface incubation and sample analysis

b. Gloved Fingertip and Thumb Sample incubation and sample analysis

c. Media Fill Testing sample incubation and sample analysis

The Contractor will assist in conducting gloved fingertip and thumb testing, media fill testing and surface sampling according to USP <797> guidelines and pharmacy needs. The Contractor shall assist with the collection, labeling and preparation of all samples. Days of sampling will be coordinated so delivery occurs according to contractor’s normal hours. The majority of testing will be conducted bi-annually (approximately 35 employees). Any additional staff needed outside of the scheduled testing week will be conducted by pharmacy designee and shipped directly to the contractor for analysis.

4. Gloved Fingertip and Thumb Sampling Plates:

Pharmacy compounding staff must be evaluated in Gloved Fingertip and Thumb Sampling (GFT) to demonstrate competency in garbing and hand hygiene, as set forth in USP <797>. The Contractor will perform GFT on site, using one sampling device per hand (e.g., plates, paddles, or slides) containing general microbial growth agar {e.g., trypticase soy agar (TSA)} supplemented with neutralizing additives (e.g., lecithin and polysorbate 80) as this agar supports both bacterial and fungal growth.

Contractor will incubate fingertip sampling plates immediately upon receipt at a temperature of 30-35° C for no less than 48 hours and then at 20°–25° C for no less than 5 additional days. Sampling plates will be stored during incubation to prevent condensate from dropping onto the agar and affecting the accuracy of the cfu reading (e.g., invert plates). Contractor will record and report the number of cfu per hand (left hand, right hand), as well as the starting temperature for each interval of incubation, dates of incubation, and the identification of the person who reads and documents the results. Contractor personnel who analyze sampling plates including reading of plates, counting cfu, and performing identification of recovered microorganisms will be a licensed and qualified environmental microbiologist.

Failure is if total cfu for both hands is greater than the action level for the type sampling (i.e., initial or bi-annual). The contractor will notify the USP Program Manager, or if unavailable, the Chief Pharmacy Services, within 1 (one) business day of any failure.

All results will be transmitted to the facility within one business day of final analysis.

Table 1. Action Level for Gloved Fingertip Sampling and Thumb Sampling

*Action levels are based on the total cfu count from both hands.

5. Surface Sample Plates:

Surface sampling plates are preferred over paddles or slides. One plate of general microbial growth agar [e.g. typticase soy agar (TSA)] supplemented with neutralizing additives (e.g. lecithin & polysorbate 80).

Microbiological surface monitoring will be performed after bi-annual media fill test is conducted by each employee as well as monthly in the IV room Suite and Segregated Compounding Contingency Area for both hazardous and non-hazardous compounding and all classified areas including:

· the interior of the Primary Engineering Controls (PECs) and any equipment contained within

· staging or work area(s) near the PEC

· Frequently touched surfaces

* Additional surface sampling may be performed during certification of new facilities and equipment, after servicing facilities or equipment, in response to identified problems, in response to identified trends, or in response to changes that could impact the sterile compounding environment.

Contractor will incubate media device(s) immediately upon receipt at a temperature of 30-35° C for no less than 48 hours. Sampling plates will be stored during incubation to prevent condensation from dropping onto the agar and affecting the accuracy of the cfu reading (e.g., invert plates). Contractor will report the total number of discrete colonies of microorganisms on each plate as cfu per sample, with sample location, and sample date. If levels measured during surface sampling exceed the levels in USP <797> Table 6, an attempt must be made to identify any microorganism recovered to the genus level, and when possible, to species of the microorganism recovered.

Contractor will incubate media device(s) at a temperature of 20-25° C for no less than 5 additional days. Sampling plates will be stored during incubation to prevent condensation from dropping onto the agar and affecting the accuracy of the cfu reading (e.g., invert plates). Contractor will report the total number of discrete colonies of microorganisms on each plate as cfu per sample, with sample location, and sample date. If levels measured during surface sampling exceed the levels in USP <797> Table 6, an attempt must be made to identify any microorganism recovered to the genus level, and when possible, to species of the microorganism recovered.

Contractor will identify which surface sampling method is included with bid.

Contractor will report the number of cfu per plate as well as the starting temperature for each interval of incubation, dates of incubation, and the identification of the person who reads and documents the results. Contractor personnel who analyze sampling plates including reading of plates, counting cfu, and performing identification of recovered microorganisms will be a licensed and qualified environmental microbiologist.

Failure is if cfu of any plate is greater than the action level for the classified area. The contractor will notify the Pharmacy Inpatient/USP 797/800 Program Manager and the Chief of Pharmacy Services, within 1 (one) business day of any failure. All results will be transmitted to the facility within one business day of final analysis.

Table 6. Action Levels for Surface Sampling

ISO Class Surface Sampling Action Levels (cfu/device or swab)

6. Media Fill Samples:

Media fill tests will be designed and developed by the Pharmacy Inpatient/USP 797/800 Program Manager to reflect the most complicated manipulations performed at WBVAMC. The contractor will be provided with the final Media Fill Testing sample (one sample) per staff member tested.

Contractor will incubate MFT samples immediately upon receipt at a temperature of 20°–25°C for 7 (seven) days followed by 7 (seven) days at 30°–35°C to detect a broad spectrum of microorganisms.

Contractor will report pass/fail results as well as the starting temperature for each interval of incubation, dates of incubation, and the identification of the person who reads and documents the results. Contractor personnel who analyze media fill including reading results licensed and qualified environmental microbiologist and or technician.

Failure is indicated by visible turbidity or other visual manifestations of growth in the media in one or more container closure unit(s) on or before 14 days. The contractor will notify the Pharmacy Inpatient/USP 797/800 Program Manager and the Chief of Pharmacy Services, within 1 (one) business day of any failure by utilizing a designated email group as provided by the facility. All results will be transmitted to the facility within one business day of final analysis.

7. Place of Performance:

Wilkes-Barre VA Medical Center 1111 East End Blvd Wilkes-Barre, PA 18711 570-824-3521 x24135

8. Contractor Qualifications:

An ISO/TEC 17025 accredited laboratory under the Environmental Microbiology Lab Accreditation Program (EMLAP). Copies of pertinent certifications, licenses and EMLAP accreditation will be required.

9. Performance requirement summary:

a. Facility surface sampling analysis for viable particles from samples taken in the Segregated Compounding Area (SCA), Chemo Ante Room, Chemo Buffer Room, IV Ante Room, IV Buffer, and associated Primary Engineering Controls (PECs)

1. Viable Surface Sampling analysis

2. Identification to at least genus for any growth that exceed the levels in USP <797> Table 6, and when possible, to species of the microorganism recovered.

b. Personnel related assessments include the following:

1. Gloved Fingertip and Thumb Sample incubation and sample analysis

2. Media Fill Testing incubation and sample analysis

3. Surface sample post media fill test incubation and analysis

10. Number of samples:

0. Initial gloved fingertip and thumb sampling-8 staff for initial testing per year (64 samples)

0. 35 staff bi-annual fingertip and thumb samples (280 samples)

0. 35 media-fill tests bi-annually (70 samples)

0. 35 staff bi-annual surface samplings conducted post media-fill (70 samples)

0. 13 total surface samplings monthly for IV compounding areas, sample locations to be determined by WBVAMC (130 samples)

0. Analysis of EM (TBC, TFC, TMC only)- per plate submitted. Covers surface samples and GFT samples from line a,b,d and e.

0. Media Fill -samples incubated per USP and FDA aseptic guidelines.be visually evaluated after 7 days of incubation at 20 to 25C and after 7 additional days of incubation at 30 to 35C for turbidity from line C.

10. Sampling Reports:

Results of viable samples and/or surface sampling must be submitted to the Pharmacy Inpatient/USP 797/800 Program Manager and the Chief of Pharmacy within one (1) business days of the receipt of the results. Failure to follow these procedures may result in delay of payment or nonpayment. Pass/Fail notifications should be included where applicable. Each sampling reports shall contain, at a minimum, the following information:

a. An SOP or protocol that describes the process for the handling, incubation and analysis for each sampling plate or MFT.

b. Growth and Sterility Control Reports (where applicable)

B.2 PRICE/COST SCHEDULE

ITEM INFORMATION

Personal Viable Particulantes Includes gloved finger sampling in which personnel touch agar with fingertips of both hands in a manner to create slight impression in agar Contract Period: Base POP Begin: 07-20-2023 POP End: 07-19-2024 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories PRODUCT/SERVICE CODE: Q301 - Medical - Laboratory Testing

USP 797 Viable Surface Testing Includes surface sampling using contact plates to detect inadequate disinfection procedures

POP Begin: 07-20-2023 POP End: 07-19-2024

USP 797 Media Fill Testing

POP Begin: 07-20-2023 POP End: 07-19-2024

Analysis of EM (TBC, TFC, TMC only)- per plate submitted. Covers surface samples and GFT samples from line 1 and 2

POP Begin: 07-20-2023 POP End: 07-19-2024

Media Fill -samples incubated per USP and FDA aseptic guidelines.be visually evaluated after 7 days of incubation at 20 to 25C and after 7 additional days of incubation at 30 to 35C for turbidity from line 3

N/C Contract Period: Base POP Begin: 07-20-2023 POP End: 07-19-2024

Personal Viable Particulantes Includes gloved finger sampling in which personnel touch agar with fingertips of both hands in a manner to create slight impression in agar Contract Period: Option 1 POP Begin: 07-20-2024 POP End: 07-19-2025

USP 797 Viable Surface Testing Includes surface sampling using contact plates to detect inadequate disinfection procedures

POP Begin: 07-20-2024 POP End: 07-19-2025

USP 797 Media Fill Testing

POP Begin: 07-20-2024 POP End: 07-19-2025

Analysis of EM (TBC, TFC, TMC only)- per plate submitted. Covers surface samples and GFT samples from line 1 and 2

POP Begin: 07-20-2024 POP End: 07-19-2025

Media Fill -samples incubated per USP and FDA aseptic guidelines.be visually evaluated after 7 days of incubation at 20 to 25C and after 7 additional days of incubation at 30 to 35C for turbidity from line 3

Contract Period: Option 1 POP Begin: 07-20-2024 POP End: 07-19-2025

Personal Viable Particulantes Includes gloved finger sampling in which personnel touch agar with fingertips of both hands in a manner to create slight impression in agar Contract Period: Option 2 POP Begin: 07-20-2025 POP End: 07-19-2026

USP 797 Viable Surface Testing Includes surface sampling using contact plates to detect inadequate disinfection procedures

POP Begin: 07-20-2025 POP End: 07-19-2026

USP 797 Media Fill Testing

POP Begin: 07-20-2025 POP End: 07-19-2026

Analysis of EM (TBC, TFC, TMC only)- per plate submitted. Covers surface samples and GFT samples from line 1 and 2

POP Begin: 07-20-2025 POP End: 07-19-2026

Media Fill -samples incubated per USP and FDA aseptic guidelines.be visually evaluated after 7 days of incubation at 20 to 25C and after 7 additional days of incubation at 30 to 35C for turbidity from line 3

Contract Period: Option 2 POP Begin: 07-20-2025 POP End: 07-19-2026

Personal Viable Particulantes Includes gloved finger sampling in which personnel touch agar with fingertips of both hands in a manner to create slight impression in agar Contract Period: Option 3 POP Begin: 07-20-2026 POP End: 07-19-2027

USP 797 Viable Surface Testing Includes surface sampling using contact plates to detect inadequate disinfection procedures

POP Begin: 07-20-2026 POP End: 07-19-2027

USP 797 Media Fill Testing

POP Begin: 07-20-2026 POP End: 07-19-2027

Analysis of EM (TBC, TFC, TMC only)- per plate submitted. Covers surface samples and GFT samples from line 1 and 2

POP Begin: 07-20-2026 POP End: 07-19-2027

Media Fill -samples incubated per USP and FDA aseptic guidelines.be visually evaluated after 7 days of incubation at 20 to 25C and after 7 additional days of incubation at 30 to 35C for turbidity from line 3

Contract Period: Option 3 POP Begin: 07-20-2026 POP End: 07-19-2027

Personal Viable Particulantes Includes gloved finger sampling in which personnel touch agar with fingertips of both hands in a manner to create slight impression in agar Contract Period: Option 4 POP Begin: 07-20-2027 POP End: 07-19-2028

USP 797 Viable Surface Testing Includes surface sampling using contact plates to detect inadequate disinfection procedures

POP Begin: 07-20-2027 POP End: 07-19-2028

USP 797 Media Fill Testing

POP Begin: 07-20-2027 POP End: 07-19-2028

Analysis of EM (TBC, TFC, TMC only)- per plate submitted. Covers surface samples and GFT samples from line 1 and 2

POP Begin: 07-20-2027 POP End: 07-19-2028

Media Fill -samples incubated per USP and FDA aseptic guidelines.be visually evaluated after 7 days of incubation at 20 to 25C and after 7 additional days of incubation at 30 to 35C for turbidity from line 3

Contract Period: Option 4 POP Begin: 07-20-2027 POP End: 07-19-2028

B.3 DELIVERY SCHEDULE

1111 East End Blvd Wilkes-Barre, PA 18711 0026

USA

360.00

(570) 824-3521 x4116 Robert.Warnagiris@va.gov

1111 East End Blvd Wilkes-Barre, PA 18711 0026

210.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

70.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

544.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

70.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

360.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

210.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

70.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

544.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

70.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

360.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

210.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

70.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

544.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

70.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

360.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

210.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

70.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

544.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

70.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

360.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

210.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

70.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

544.00

1111 East End Blvd Wilkes-Barre, PA 18711 0026

70.00

SECTION C - CONTRACT CLAUSES

C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (DEC 2022)

(a) Inspection/Acceptance. The Contractor shall only tender for acceptance those items that conform to the requirements of this contract. The Government reserves the right to inspect or test any supplies or services that have been tendered for acceptance. The Government may require repair or replacement of nonconforming supplies or reperformance of nonconforming services at no increase in contract price. If repair/replacement or reperformance will not correct the defects or is not possible, the Government may seek an equitable price reduction or adequate consideration for acceptance of nonconforming supplies or services. The Government must exercise its post-acceptance rights—

(1) Within a reasonable time after the defect was discovered or should have been discovered; and

(2) Before any substantial change occurs in the condition of the item, unless the change is due to the defect in the item.

(b) Assignment. The Contractor or its assignee may assign its rights to receive payment due as a result of performance of this contract to a bank, trust company, or other financing institution, including any Federal lending agency in accordance with the Assignment of Claims Act (31 U.S.C. 3727). However, when a third party makes payment (e.g., use of the Governmentwide commercial purchase card), the Contractor may not assign its rights to receive payment under this contract.

(c) Changes. Changes in the terms and conditions of this contract may be made only by written agreement of the parties.

(d) Disputes. This contract is subject to 41 U.S.C. chapter 71, Contract Disputes. Failure of the parties to this contract to reach agreement on any request for equitable adjustment, claim, appeal or action arising under or relating to this contract shall be a dispute to be resolved in accordance with the clause at Federal Acquisition Regulation (FAR) 52.233-1, Disputes, which is incorporated herein by reference. The Contractor shall proceed diligently with performance of this contract, pending final resolution of any dispute arising under the contract.

(e) Definitions. The clause at FAR 52.202-1, Definitions, is incorporated herein by reference.

(f) Excusable delays. The Contractor shall be liable for default unless nonperformance is caused by an occurrence beyond the reasonable control of the Contractor and without its fault or negligence such as, acts of God or the public enemy, acts of the Government in either its sovereign or contractual capacity, fires, floods, epidemics, quarantine restrictions, strikes, unusually severe weather, and delays of common carriers. The Contractor shall notify the Contracting Officer in writing as soon as it is reasonably possible after the commencement of any excusable delay, setting forth the full particulars in connection therewith, shall remedy such occurrence with all reasonable dispatch, and shall promptly give written notice to the Contracting Officer of the cessation of such occurrence.

(g) Invoice.

(1) The Contractor shall submit an original invoice and three copies (or electronic invoice, if authorized) to the address designated in the contract to receive invoices. An invoice must include—

(i) Name and address of the Contractor;

(ii) Invoice date and number;

(iii) Contract number, line item number and, if applicable, the order number;

(iv) Description, quantity, unit of measure, unit price and extended price of the items delivered;

(v) Shipping number and date of shipment, including the bill of lading number and weight of shipment if shipped on Government bill of lading;

(vi) Terms of any discount for prompt payment offered;

(vii) Name and address of official to whom payment is to be sent;

(viii) Name, title, and phone number of person to notify in event of defective invoice; and

(ix) Taxpayer Identification Number (TIN). The Contractor shall include its TIN on the invoice only if required elsewhere in this contract.

(x) Electronic funds transfer (EFT) banking information.

(A) The Contractor shall include EFT banking information on the invoice only if required elsewhere in this contract.

(B) If EFT banking information is not required to be on the invoice, in order for the invoice to be a proper invoice, the Contractor shall have submitted correct EFT banking information in accordance with the applicable solicitation provision, contract clause (e.g., 52.232-33, Payment by Electronic Funds Transfer—System for Award Management, or 52.232-34, Payment by Electronic Funds Transfer—Other Than System for Award Management), or applicable agency procedures.

(C) EFT banking information is not required if the Government waived the requirement to pay by EFT.

(2) Invoices will be handled in accordance with the Prompt Payment Act (31 U.S.C. 3903) and Office of Management and Budget (OMB) prompt payment regulations at 5 CFR part 1315.

(h) Patent indemnity. The Contractor shall indemnify the Government and its officers, employees and agents against liability, including costs, for actual or alleged direct or contributory infringement of, or inducement to infringe, any United States or foreign patent, trademark or copyright, arising out of the performance of this contract, provided the Contractor is reasonably notified of such claims and proceedings.

(i) Payment.—

(1) Items accepted. Payment shall be made for items accepted by the Government that have been delivered to the delivery destinations set forth in this contract.

(2) Prompt payment. The Government will make payment in accordance with the Prompt Payment Act (31 U.S.C. 3903) and prompt payment regulations at 5 CFR part 1315.

(3) Electronic Funds Transfer (EFT). If the Government makes payment by EFT, see 52.212-5(b) for the appropriate EFT clause.

(4) Discount. In connection with any discount offered for early payment, time shall be computed from the date of the invoice. For the purpose of computing the discount earned, payment shall be considered to have been made on the date which appears on the payment check or the specified payment date if an electronic funds transfer payment is made.

(5) Overpayments. If the Contractor becomes aware of a duplicate contract financing or invoice payment or that the Government has otherwise overpaid on a contract financing or invoice payment, the Contractor shall—

(i) Remit the overpayment amount to the payment office cited in the contract along with a description of the overpayment including the—

(A) Circumstances of the overpayment (e.g., duplicate payment, erroneous payment, liquidation errors, date(s) of overpayment);

(B) Affected contract number and delivery order number, if applicable;

(C) Affected line item or subline item, if applicable; and

(D) Contractor point of contact.

(ii) Provide a copy of the remittance and supporting documentation to the Contracting Officer.

(6) Interest.

(i) All amounts that become payable by the Contractor to the Government under this contract shall bear simple interest from the date due until paid unless paid within 30 days of becoming due. The interest rate shall be the interest rate established by the Secretary of the Treasury as provided in 41 U.S.C. 7109, which is applicable to the period in which the amount becomes due, as provided in (i)(6)(v) of this clause, and then at the rate applicable for each six-month period as fixed by the Secretary until the amount is paid.

(ii) The Government may issue a demand for payment to the Contractor upon finding a debt is due under the contract.

(iii) Final decisions. The Contracting Officer will issue a final decision as required by 33.211 if—

(A) The Contracting Officer and the Contractor are unable to reach agreement on the existence or amount of a debt within 30 days;

(B) The Contractor fails to liquidate a debt previously demanded by the Contracting Officer within the timeline specified in the demand for payment unless the amounts were not repaid because the Contractor has requested an installment payment agreement; or

(C) The Contractor requests a deferment of collection on a debt previously demanded by the Contracting Officer (see 32.607-2).

(iv) If a demand for payment was previously issued for the debt, the demand for payment included in the final decision shall identify the same due date as the original demand for payment.

(v) Amounts shall be due at the earliest of the following dates:

(A) The date fixed under this contract.

(B) The date of the first written demand for payment, including any demand for payment resulting from a default termination.

(vi) The interest charge shall be computed for the actual number of calendar days involved beginning on the due date and ending on—

(A) The date on which the designated office receives payment from the Contractor;

(B) The date of issuance of a Government check to the Contractor from which an amount otherwise payable has been withheld as a credit against the contract debt; or

(C) The date on which an amount withheld and applied to the contract debt would otherwise have become payable to the Contractor.

(vii) The interest charge made under this clause may be reduced under the procedures prescribed in FAR 32.608-2 in effect on the date of this contract.

(j) Risk of loss. Unless the contract specifically provides otherwise, risk of loss or damage to the supplies provided under this contract shall remain with the Contractor until, and shall pass to the Government upon:

(1) Delivery of the supplies to a carrier, if transportation is f.o.b. origin; or

(2) Delivery of the supplies to the Government at the destination specified in the contract, if transportation is f.o.b. destination.

(k) Taxes. The contract price includes all applicable Federal, State, and local taxes and duties.

(l) Termination for the Government's convenience. The Government reserves the right to terminate this contract, or any part hereof, for its sole convenience. In the event of such termination, the Contractor shall immediately stop all work hereunder and shall immediately cause any and all of its suppliers and subcontractors to cease work. Subject to the terms of this contract, the Contractor shall be paid a percentage of the contract price reflecting the percentage of the work performed prior to the notice of termination, plus reasonable charges the Contractor can demonstrate to the satisfaction of the Government using its standard record keeping system, have resulted from the termination. The Contractor shall not be required to comply with the cost accounting standards or contract cost principles for this purpose. This paragraph does not give the Government any right to audit the Contractor's records. The Contractor shall not be paid for any work performed or costs incurred which reasonably could have been avoided.

(m) Termination for cause. The Government may terminate this contract, or any part hereof, for cause in the event of any default by the Contractor, or if the Contractor fails to comply with any contract terms and conditions, or fails to provide the Government, upon request, with adequate assurances of future performance. In the event of termination for cause, the Government shall not be liable to the Contractor for any amount for supplies or services not accepted, and the Contractor shall be liable to the Government for any and all rights and remedies provided by law. If it is determined that the Government improperly terminated this contract for default, such termination shall be deemed a termination for convenience.

(n) Title. Unless specified elsewhere in this contract, title to items furnished under this contract shall pass to the Government upon acceptance, regardless of when or where the Government takes physical possession.

(o) Warranty. The Contractor warrants and implies that the items delivered hereunder are merchantable and fit for use for the particular purpose described in this contract.

(p) Limitation of liability. Except as otherwise provided by an express warranty, the Contractor will not be liable to the Government for consequential damages resulting from any defect or deficiencies in accepted items.

(q) Other compliances. The Contractor shall comply with all applicable Federal, State and local laws, executive orders, rules and regulations applicable to its performance under this contract.

(r) Compliance with laws unique to Government contracts. The Contractor agrees to comply with 31 U.S.C. 1352 relating to limitations on the use of appropriated funds to influence certain Federal contracts; 18 U.S.C. 431 relating to officials not to benefit; 40 U.S.C. chapter 37, Contract Work Hours and Safety Standards; 41 U.S.C. chapter 87, Kickbacks; 41 U.S.C. 4712 and 10 U.S.C. 4701 relating to whistleblower protections; 49 U.S.C. 40118, Fly American; and 41 U.S.C. chapter 21 relating to procurement integrity.

(s) Order of precedence. Any inconsistencies in this solicitation or contract shall be resolved by giving precedence in the following order:

(1) The schedule of supplies/services.

(2) The Assignments, Disputes, Payments, Invoice, Other Compliances, Compliance with Laws Unique to Government Contracts, and Unauthorized Obligations paragraphs of this clause;

(3) The clause at 52.212-5.

(4) Addenda to this solicitation or contract, including any license agreements for computer software.

(5) Solicitation provisions if this is a solicitation.

(6) Other paragraphs of this clause.

(7) The Standard Form 1449.

(8) Other documents, exhibits, and attachments

(9) The specification.

(t) [Reserved]

(u) Unauthorized Obligations.

(1) Except as stated in paragraph (u)(2) of this clause, when any supply or service acquired under this contract is subject to any End User License Agreement (EULA), Terms of Service (TOS), or similar legal instrument or agreement, that includes any clause requiring the Government to indemnify the Contractor or any person or entity for damages, costs, fees, or any other loss or liability that would create an Anti-Deficiency Act violation (31 U.S.C. 1341), the following shall govern:

(i) Any such clause is unenforceable against the Government.

(ii) Neither the Government nor any Government authorized end user shall be deemed to have agreed to such clause by virtue of it appearing in the EULA, TOS, or similar legal instrument or agreement. If the EULA, TOS, or similar legal instrument or agreement is invoked through an “I agree” click box or other comparable mechanism (e.g., “click-wrap” or “browse-wrap” agreements), execution does not bind the Government or any Government authorized end user to such clause.

(iii) Any such clause is deemed to be stricken from the EULA, TOS, or similar legal instrument or agreement.

(2) Paragraph (u)(1) of this clause does not apply to indemnification by the Government that is expressly authorized by statute and specifically authorized under applicable agency regulations and procedures.

(v) Incorporation by reference. The Contractor’s representations and certifications, including those completed electronically via the System for Award Management (SAM), are incorporated by reference into the contract.

(End of Clause) ADDENDUM to FAR 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES Clauses that are incorporated by reference (by Citation Number, Title, and Date), have the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available.

The following clauses are incorporated into 52.212-4 as an addendum to this contract:

C.2 52.217-6 OPTION FOR INCREASED QUANTITY (MAR 1989)

The Government may increase the quantity of supplies called for in the Schedule at the unit price specified. The Contracting Officer may exercise the option by written notice to the Contractor within 30 days. Delivery of the added items shall continue at the same rate as the like items called for under the contract, unless the parties otherwise agree.

(End of Clause)

C.3 VAAR 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (NOV 2018)

(a) Definitions. As used in this clause—

(1) Contract financing payment has the meaning given in FAR 32.001;

(2) Designated agency office means the office designated by the purchase order, agreement, or contract to first receive and review invoices. This office can be contractually designated as the receiving entity. This office may be different from the office issuing the payment;

(3) Electronic form means an automated system transmitting information electronically according to the accepted electronic data transmission methods and formats identified in paragraph (c) of this clause. Facsimile, email, and scanned documents are not acceptable electronic forms for submission of payment requests;

(4) Invoice payment has the meaning given in FAR 32.001; and

(5) Payment request means any request for contract financing payment or invoice payment submitted by the contractor under this contract.

(b) Electronic payment requests. Except as provided in paragraph (e) of this clause, the contractor shall submit payment requests in electronic form. Purchases paid with a Government-wide commercial purchase card are considered to be an electronic transaction for purposes of this rule, and therefore no additional electronic invoice submission is required.

(c) Data transmission. A contractor must ensure that the data transmission method and format are through one of the following:

(1) VA’s Electronic Invoice Presentment and Payment System at the current website address provided in the contract.

(2) Any system that conforms to the X12 electronic data interchange (EDI) formats established by the Accredited Standards Center (ASC) and chartered by the American National Standards Institute (ANSI).

(d) Invoice requirements. Invoices shall comply with FAR 32.905.

(e) Exceptions. If, based on one of the circumstances in this paragraph (e), the Contracting Officer directs that payment requests be made by mail, the Contractor shall submit payment requests by mail through the United States Postal Service to the designated agency office. Submission of payment requests by mail may be required for—

(1) Awards made to foreign vendors for work performed outside the United States;

(2) Classified contracts or purchases when electronic submission and processing of payment requests could compromise the safeguarding of classified or privacy information;

(3) Contracts awarded by contracting officers in the conduct of emergency operations, such as responses to national emergencies;

(4) Solicitations or contracts in which the designated agency office is a VA entity other than the VA Financial Services Center in Austin, Texas; or

(5) Solicitations or contracts in which the VA designated agency office does not have electronic invoicing capability as described above.

(End of Clause)

C.4 VAAR 852.242-71 ADMINISTRATIVE CONTRACTING OFFICER (OCT 2020)

The Contracting Officer reserves the right to designate an Administrative Contracting Officer (ACO) for the purpose of performing certain tasks/duties in the administration of the contract. Such designation will be in writing through an ACO Letter of Delegation and will identify the responsibilities and limitations of the ACO. A copy of the ACO Letter of Delegation will be furnished to the Contractor.

(End of Clause)

C.5 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es):

https://www.acquisition.gov/browse/index/far…